U.S. markets close in 3 hours 31 minutes

SANUWAVE Health, Inc. (SNWV)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0900+0.0100 (+12.50%)
As of 12:11PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0800 - 0.0900
52 Week Range0.0001 - 0.2200
Avg. Volume93,588
Market Cap44.688M
Beta (5Y Monthly)-0.24
PE Ratio (TTM)N/A
EPS (TTM)-0.0610
Earnings DateNov 17, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SNWV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    ORGO: Rating decreased to a SELLORGANOGENESIS HOLDINGS INC has an Investment Rating of SELL; a target price of $6.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • GlobeNewswire

    SANUWAVE Health Announces Patent Activity from March 2021 to March 2022

    SANUWAVE announces patents issued over the past year SUWANEE, GA, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV) focuses on the development and commercialization of innovative advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications of shockwave and ultrasound systems in the non-medical field, announced today the patent activity for the past year. For the shockwave technology, th

  • GlobeNewswire

    SANUWAVE Announces New Board Leadership

    SANUWAVE announces addition of three new board members this quarter SUWANEE, GA, April 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, today announced three new board members will join as one departs. “We are excited to expand our board with three new members who will help us reach new heights by bringing diverse expertise and insight to our work,” said SANUWAVE CEO & Chairman of the Board Kevin A. Richardson,

  • GlobeNewswire

    SANUWAVE® Business Update

    Sales Funnel and System Trials Increase 13% Month Over MonthLaunches Entry into Two New Vertical Markets; Initial Orders Exceed $1 million SUWANEE, GA, April 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, has announced they will be updating shareholders on a monthly basis during 2022 with regards to their Sales Funnel and System Trials. This news comes simultaneously with the company’s announcement for grow